Clinical Trial

Imaging Genetics of Spasmodic Dysphonia

Study Description

Imaging Genetics of Spasmodic Dysphonia

The contribution of genetic risk factors to the development of focal dystonias is evident. However, understanding of how variations in the causative gene expression lead to variations in brain abnormalities in different phenotypes of dystonia (e.g., familial, sporadic) remains limited. The research program of the investigators is set to determine the relationship between brain changes and genetic risk factors in spasmodic dysphonia (or laryngeal dystonia). The researchers use a novel approach of combined imaging genetics, next-generation DNA sequencing, and clinico-behavioral testing. The use of a cross-disciplinary approach as a tool for discovery of the mediating neural mechanisms that bridge the gap from DNA sequence to pathophysiology of dystonia holds a promise for the understanding of the mechanistic aspects of brain function affected by risk gene variants, which can be used reliably for discovery of associated genes and neural integrity markers for this disorder. The expected outcome of this study may lead to better clinical management of this disorder, including its improved detection, accurate diagnosis, and assessment of the risk to develop spasmodic dysphonia in family members.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

MRI

Functional and structural MRI of the brain will be conducted to identify disorder specific neural markers

Procedure - Blood draw

Blood samples will be collected, the DNA will be extracted and banked for genetic studies.

Additional Information

Official Study Title

Imaging Genetics of Spasmodic Dysphonia

Clinical Trial ID

NCT03042975

ParticipAid ID

meplNe